18.07.2012 • NewsDSMCollaborationcooperation

DSM, Recepta Announce Contract Manufacturing Agreement

DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced that it has signed a biologics contract manufacturing agreement with its first Brazilian client, Recepta Biopharma in São Paulo.

The contract covers the process development and cGMP manufacture by DSM of one of Recepta's lead antibodies at its facilities based in Groningen, The Netherlands. DSM started production to supply drug substance materials to be used in the initial clinical trials of this antibody beginning in May of 2012.

This project represents DSM Biologics first agreement in the high growth South American market place. Recepta Biopharma is a biotechnology company dedicated to the research and development of monoclonal antibodies to be used in the treatment of cancer.

In addition to the R&D and manufacturing site in Groningen, DSM is building operations in Brisbane, Australia, with the governments of Queensland and the Commonwealth.

Financial terms were not disclosed.

 

 

 

 

 

 

 

 

 

 

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.